This event seeks to promote the multidisciplinary management of glioma patients, which is critical to ensure that patients receive appropriate treatment and care at the right time in order to maximize the survival and the quality of life. 
The program consists of three multidisciplinary case-based discussions around the management of patients with glioma combined with short lectures focusing on the practical aspects, emphasizing the evidence base that underpins management decisions. Case discussions will be led by a multidisciplinary panel of experts, with the audience encouraged to participate in the discussion. 
The event is aimed at residents, medical specialists and nurses working in the field of neuro-oncology.

Time & date: Wednesday, October 15, 2025, from 13:00 to 16:00hrs CEST
Where: Prague, Czech Republic
Venue: Prague Congress Centre, 5. kvetna 1640/65, Nusle, 140 21 Prague 4, CZ
Registration fee: Free for all EANO Members

Note that the program is subject to change and will be continuously updated.
All times below refer to Central European Summer Time (CEST).

13:00 - 13:05  Welcome and Introduction
Stephen Price, United Kingdom
Matthijs van der Meulen, The Netherlands
13:05 - 13:20  Shared decision making
Lena Rosenlund, Sweden
13:20- 13:50  Case 1 (panel discussion)
Panelists: TBA
13:50 - 14:00  How to define progression during follow-up Imaging (MRI and PET)
Jan-Michael Werner, Germany
14:00 - 14:30  Case 2 (panel discussion)
Panelists: TBA
14:30 - 14:40  Pathology: value of NGS, methylation and individual mutations
Laetitia Lebrun, Belgium

14:40 - 15:00  Coffee break

15:00-15:30  Case 3 (panel discussion)
Panelists: TBA
15:30 - 15:40  Surgical and rehabilitation aspects after surgery in SMA area 
Stephen Price, United Kingdom
15:40 - 15:55  Practical Guide to Using Vorasidenib: When and How to Use It
TBA

15:55 - 16:00  Q&A

This program is supported by Servier.

These Terms & Conditions apply to every person registering for the EANO Tumor Board 2025: Multidisciplinary management of patients with glioma, to be held in Prague, Czech Republic, on October 15, 2025, organised by the EANO - European Association of Neuro-Oncology (hereafter referred to as "the event organiser").